-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Upgrades Celestica to Buy, Raises Price Target to $430

Benzinga·08/24/2026 13:41:56
Listen to the news
UBS analyst David Vogt upgrades Celestica (NYSE:CLS) from Neutral to Buy and raises the price target from $410 to $430.